Researcher biography

Dr Luis Furuya Kanamori MBBS, MEpi, MPH, PhD, FACTM is a clinical epidemiologist and research synthesis methodologist. He is an international leader in travel medicine, vaccine preventable diseases, and research synthesis, and has been listed in Stanford University's World top 2% of scientists.

Dr Furuya Kanamori leads the Travel Medicine and Vaccine Preventable Diseases Theme, and the Clinician-Epidemiologist Hub at UQ's HERA program on Operational Research and Decision Support for Infectious Diseases (ODeSI). He is Director of Research of the Clinical Research & Evidence Synthesis (CRESTMA) at the Travel Medicine Alliance (TMA), network of >30 travel medicine clinics in Australia.

Dr Furuya Kanamori's applied research on travel medicine and vaccine preventable diseases has influenced key changes in clinical and public health guidelines (e.g., WHO, ATAGI, Australian Immunisation Handbook, UptoDate). His methodological work on publication bias (LFK index) has been implemented in MetaXL, Stata, and R, and has been utilised in >800 published meta-analyses.

In addition to his academic roles, Dr Furuya Kanamori is editorial board member for J Travel Med and Clin Infect Dis, and chairs the Research and Awards Committee of the International Society of Travel Medicine.